Alphatec Holdings Inc(ATEC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 30 at 7:59 PM ET (Korea 10/31 08:59)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.56 | Insider Own | 21.8% | Shs Outstand | 153.4M | Perf Week | -36.63% |
| Market Cap | 1.09B | Forward P/E | 12.23 | EPS next Y | 89.89% | Insider Trans | 0.71% | Shs Float | 120.8M | Perf Month | -28.89% |
| Enterprise Value | 1.62B | PEG | 0.08 | EPS next Q | 0.13 | Inst Own | 74.4% | Short Float | 11% | Perf Quarter | -30.64% |
| Income | -0.09B | P/S | 1.29 | EPS this Y | 506.27% | Inst Trans | -0.59% | Short Ratio | 5.56 | Perf Half Y | -32.5% |
| Sales | 0.84B | P/B | - | EPS next 5Y | 155.48% | ROA | -10.97% | Short Interest | 13.28M | Perf YTD | -66.54% |
| Book/sh | -0.02 | P/C | 13.6 | EPS past 3/5Y | 13.26% 4.12% | ROE | -308.06% | 52W High | -69.77% ($23.29) | Perf Year | -56.89% |
| Cash/sh | 0.52 | P/FCF | 354.18 | Sales past 3/5Y | 29.62% 39.46% | ROIC | -14.32% | 52W Low | 3.23% ($6.82) | Perf 3Y | -20.81% |
| Dividend Est. | - | EV/EBITDA | 27.9 | EPS Y/Y TTM | 36.87% | Gross Margin | 61.9% | Volatility(W/M) | 4.9% 5.02% | Perf 5Y | -39.98% |
| Dividend TTM | - | EV/Sales | 1.94 | Sales Y/Y TTM | 15.34% | Oper. Margin | -3.05% | ATR (14) | 0.81 | Perf 10Y | 12.1% |
| Dividend Ex-Date | - | Quick Ratio | 1.22 | EPS Q/Q | 81.57% | Profit Margin | -10.35% | RSI (14) | 27.16 | Recom | 1.14 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.36 | Sales Q/Q | 12.55% | SMA20 | -33.79% ($10.63) | Beta | 0.83 | Target Price | $14.25 |
| Payout | - | Debt/Eq | 27.88 | Earnings | 2026/10/29 | SMA50 | -30.57% ($10.14) | Rel Volume | 11.2 | Prev Close | $11.37 |
| Employees | 913 | LT Debt/Eq | 27.48 | EPS/Sales Surpr. | -5.36% -1.77% | SMA200 | -33.32% ($10.56) | Avg Volume(3M) | 2.39M | Price | $7.04 |
| IPO | 2006/6/2 | Option/Short | Yes/Yes | Trades | 81198 | Volume | 26,764,149 | Change | -38.08% |
Alpha Tech Holdings is a U.S. medical device company specializing in spine disease surgery. The company develops an integrated platform for spine surgeons that combines implants, biomaterials, and surgical navigation, robotics, and neuromonitoring, and is rapidly expanding its market share in the spine surgery field through surgical information technology.
Over the past 1 year, on the lower side
70% below its 1-year high.
Traded more than usual. That is 1120% of its average volume.
ATEC has a sound balance sheet but weak earning power
Of every $100 in sales, $3.05 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +506.3% this year.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $129. Peers typically go for $326.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -40.0%. The S&P 500 did +65% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 74.4%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #40 of 142 in the industry
Based on market cap of $1B.
BVS#36 Bioventus Inc $1B PER 17.2 
AORT#37 Artivion Inc $1B PER - 
PRCT#38 Procept BioRobotics Corp $1B PER - 
LMRI#39 Lumexa Imaging Holdings Inc $1B PER - ATEC#40 Alphatec Holdings Inc $1B PER - 
FAQ
What kind of company is ATEC?
ATEC belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of ATEC?
The market cap of ATEC is approximately $1.1B, ranking 2,508 within its sector.
What is the 52-week high and low for ATEC?
ATEC has recorded a 52-week high of $23.29 and a low of $6.82.
